Clinical Trial Update: Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating 18F-PSMA-11 PET imaging for detection of lesions in iodine-refractory thyroid cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• 18F-PSMA-11 (PSMA-11 radiotracer (fluorine-18 labeled))

Snippet

Sponsor: University Hospital, Ghent | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED